Gabriel Sica

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	27600	16429
h-endeksi	49	37
i10-endeksi	85	69

3600

1800

900

2700

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202586 115 127 145 167 157 157 207 186 235 273 374 464 827 1337 1687 1997 2432 2939 3431 3501 3115 2895 544

Genel erişim

Tümünü görüntüle

67 makale

1 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Taofeek K. Owonikoko, MD/PhDUniversity of Pittsburghupmc.edu üzerinde doğrulanmış e-posta adresine sahip
Fadlo R. KhuriPresident and Professor, American University of Beirutaub.edu.lb üzerinde doğrulanmış e-posta adresine sahip
Zhengjia ChenUniveristy of Illinois at Chicagouic.edu üzerinde doğrulanmış e-posta adresine sahip
Walter CurranChief of Piedmont Oncology Institutepiedmont.org üzerinde doğrulanmış e-posta adresine sahip
Lieping ChenYale Universityyale.edu üzerinde doğrulanmış e-posta adresine sahip
Shi-Yong SunEmory Universityemory.edu üzerinde doğrulanmış e-posta adresine sahip
Michael R. Rossi, Ph.D.VP Translational Science and Multimodal RWEconcertai.com üzerinde doğrulanmış e-posta adresine sahip
Rafi AhmedDirector of Emory Vaccine Centeremory.edu üzerinde doğrulanmış e-posta adresine sahip
Dong Moon Shin, MD, FACPFrances Kelly Blomeyer Distinguished Chair in Cancer Research, Professor of Hematology and Medicalemory.edu üzerinde doğrulanmış e-posta adresine sahip
Haian FuProfessor of Pharmacology, Emory Universityemory.edu üzerinde doğrulanmış e-posta adresine sahip
Melissa Gilbert-RossAssistant Professor of Hematology and Medical Oncology, The Emory School of Medicineemory.edu üzerinde doğrulanmış e-posta adresine sahip
William TravisMemorial Sloan Kettering Cancer Centermskcc.org üzerinde doğrulanmış e-posta adresine sahip
conor steuerWinship Cancer Institute of Emory Universityemory.edu üzerinde doğrulanmış e-posta adresine sahip
Andrei ChapovalAltai State Universityemail.asu.ru üzerinde doğrulanmış e-posta adresine sahip
nabil sabaProfessor and Vice Chair, Lynne and Howard Halpern Chair in Head and Neck Cancer Researchemory.edu üzerinde doğrulanmış e-posta adresine sahip
Adam I MarcusProfessor, Winship Cancer Institute, Emory Universityemory.edu üzerinde doğrulanmış e-posta adresine sahip
Jian Ni 倪健Nuance Biotech Co. Ltd.，优锐生物医药科技有限公司nuancebiotech.com üzerinde doğrulanmış e-posta adresine sahip
Haidong Dong, MD, PhD.Professor of Immunology, Mayo Clinicmayo.edu üzerinde doğrulanmış e-posta adresine sahip
Wei ZhouEmory University School of Medicineemory.edu üzerinde doğrulanmış e-posta adresine sahip
Ryan Wilcoxmed.umich.edu üzerinde doğrulanmış e-posta adresine sahip

Takip et

Gabriel Sica

UPMC

upmc.edu üzerinde doğrulanmış e-posta adresine sahip

Lung pathology Tumor immunology


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018	5044	2018
Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014	4120	2014
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015	2937	2015
Integrated genomic characterization of papillary thyroid carcinoma N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ... Cell 159 (3), 676-690, 2014	2767	2014
Integrated genomic characterization of oesophageal carcinoma Cancer Genome Atlas Research Network Nature 541 (7636), 169, 2017	1414	2017
B7-H3: a costimulatory molecule for T cell activation and IFN-γ production AI Chapoval, J Ni, JS Lau, RA Wilcox, DB Flies, D Liu, H Dong, GL Sica, ... Nature immunology 2 (3), 269-274, 2001	1323	2001
B7-H4, a molecule of the B7 family, negatively regulates T cell immunity GL Sica, IH Choi, G Zhu, K Tamada, SD Wang, H Tamura, AI Chapoval, ... Immunity 18 (6), 849-861, 2003	1061	2003
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent AO Kamphorst, A Wieland, T Nasti, S Yang, R Zhang, DL Barber, ... Science 355 (6332), 1423-1427, 2017	1009	2017
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients AO Kamphorst, RN Pillai, S Yang, TH Nasti, RS Akondy, A Wieland, ... Proceedings of the National Academy of Sciences 114 (19), 4993-4998, 2017	823	2017
Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination BD Robinson, GL Sica, YF Liu, TE Rohan, FB Gertler, JS Condeelis, ... Clinical cancer research 15 (7), 2433-2441, 2009	415	2009
A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors G Sica, A Yoshizawa, CS Sima, CG Azzoli, RJ Downey, VW Rusch, ... The American journal of surgical pathology 34 (8), 1155-1162, 2010	384	2010
Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway K Tamada, K Shimozaki, AI Chapoval, G Zhu, G Sica, D Flies, T Boone, ... Nature medicine 6 (3), 283-289, 2000	380	2000
Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family IH Choi, G Zhu, GL Sica, SE Strome, JC Cheville, JS Lau, Y Zhu, DB Flies, ... The Journal of Immunology 171 (9), 4650-4654, 2003	367	2003
B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function H Tamura, H Dong, G Zhu, GL Sica, DB Flies, K Tamada, L Chen Blood, The Journal of the American Society of Hematology 97 (6), 1809-1816, 2001	357	2001
The integrated genomic landscape of thymic epithelial tumors M Radovich, CR Pickering, I Felau, G Ha, H Zhang, H Jo, KA Hoadley, ... Cancer cell 33 (2), 244-258. e10, 2018	345	2018
Vimentin is required for lung adenocarcinoma metastasis via heterotypic tumor cell–cancer-associated fibroblast interactions during collective invasion AM Richardson, LS Havel, AE Koyen, JM Konen, J Shupe, WG Wiles IV, ... Clinical cancer research 24 (2), 420-432, 2018	235	2018
Characteristics and outcomes of patients with metastatic KRAS-mutant lung adenocarcinomas: the lung cancer mutation consortium experience B El Osta, M Behera, S Kim, LD Berry, G Sica, RN Pillai, TK Owonikoko, ... Journal of thoracic oncology 14 (5), 876-889, 2019	214	2019
Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression N Putluri, A Shojaie, VT Vasu, SK Vareed, S Nalluri, V Putluri, ... Cancer research 71 (24), 7376-7386, 2011	213	2011
Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer S You, R Li, D Park, M Xie, GL Sica, Y Cao, ZQ Xiao, X Deng Molecular cancer therapeutics 13 (3), 606-616, 2014	194	2014
Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non–small cell lung cancer R Li, Z Hu, SY Sun, ZG Chen, TK Owonikoko, GL Sica, SS Ramalingam, ... Molecular cancer therapeutics 12 (10), 2200-2212, 2013	183	2013

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar